• Complex, synthetic or biological active (bio)pharmaceutical ingredients and corresponding drug product manufacturing activities (peptides, oligonucleotides, antibody-drug conjugates (ADCs), highly active and cytotoxic NCEs, biosimilars and vaccine)
  • Aseptic liquid fills (vials, PFS) and lyophilized fills (vials)
  • R&D, manufacturing and technology transfer projects: project definition, integration and management (project compliance, scope creep prevention and overall project management, “person in the plant” concept
  • Process development, scaling-up, validation, criticality assessments
  • Process changes, cost/benefit assessment and recommendation
  • Process and technology transfers